Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors

Journal of Medicinal Chemistry
1983.0

Abstract

The enantiomers [(S)-(+) and (R)-(-)] of N-n-propylnorapomorphine (NPA) were synthesized. (R)-NPA was obtained by the acid-catalyzed rearrangement of N-n-propylnormorphine. (R)-NPA also was converted to (RS)-N-n-propylnorapomorphine dimethyl ether by dehydrogenation of the 10,11-O,O'-dimethyl ether of (R)-NPA with 10% palladium on carbon in acetonitrile, followed by reduction with sodium cyanoborohydride under acidic conditions. Alternatively (RS)-NPA 10,11-O,O'-dimethyl ether was obtained via total synthesis. (+)-Dibenzoyl-D-tartaric acid was used to resolve (RS)-NPA dimethyl ether. Ether cleavage gave (S)-NPA isolated as the hydrochloride salt in greater than 99.9% enantiomeric purity, as determined by circular dichroism (CD) spectra. The pharmacological activities of (S)- and (R)-NPA were evaluated with subnanomolar concentrations of 3H-labeled apomorphine (APO), ADTN, and spiroperidol (SPR) for competition for binding to a membrane-rich subsynaptosomal fraction of calf caudate nucleus. IC50 (nM) values for (R)-NPA vs. (S)-NPA were as follows: [3H]APO, 2.5 vs. 66; [3H]ADTN, 2.0 vs. 60; [3H]SPR, 174 vs. 1400. The efficacy of (R)- and (S)-NPA in stimulating dopamine-sensitive adenylate cyclase from both homogenates of rat corpus striatum and pieces of intact carp retina was also evaluated. Three behavioral effects in the rat (stereotyped behavior, sedation, and catalepsy) were also examined. Only (R)-NPA induced stereotypy; (S)-NPA failed to antagonize this action of the R isomer. The effects of (R)- and (S)-NPA on adenylate cyclase agreed with the behavioral effects and radioreceptor binding assays in that the R isomer was the strongly preferred enantiomer at dopamine receptors. The S enantiomer of NPA was, however, the weakly preferred configuration for rat liver catechol O-methyltransferase. A dopamine-receptor model accommodates the configuration of NPA and related aporphines.

Knowledge Graph

Similar Paper

Aporphines. 48. Enantioselectivity of (R)-(-)- and (S)-(+)-N-n-propylnorapomorphine on dopamine receptors
Journal of Medicinal Chemistry 1983.0
Aporphines. 14. Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-propylnoraporphine
Journal of Medicinal Chemistry 1976.0
Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine
Journal of Medicinal Chemistry 1982.0
Synthesis and dopaminergic properties of the two enantiomers of 3-(3,4-dimethylphenyl)-1-propylpiperidine, a potent and selective dopamine D4 receptor ligand
Bioorganic & Medicinal Chemistry Letters 2001.0
Aporphines. 21. Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines
Journal of Medicinal Chemistry 1977.0
Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity
Journal of Medicinal Chemistry 1981.0
Aporphines. 58. N-(2-Chloroethyl)[8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application
Journal of Medicinal Chemistry 1984.0
Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine
Journal of Medicinal Chemistry 1984.0
Structure-activity relationships of N-substituted dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene analogs: behavioral effects in lesioned and reserpinized mice
Journal of Medicinal Chemistry 1979.0
Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Journal of Medicinal Chemistry 1982.0